US6897017B1
(en)
*
|
1997-01-31 |
2005-05-24 |
Odyssey Thera Inc. |
Vivo library-versus-library selection of optimized protein-protein interactions
|
US20020064769A1
(en)
*
|
2000-10-05 |
2002-05-30 |
Watson Michnick Stephen William |
Dynamic visualization of expressed gene networks in living cells
|
CA2196496A1
(en)
*
|
1997-01-31 |
1998-07-31 |
Stephen William Watson Michnick |
Protein fragment complementation assay for the detection of protein-protein interactions
|
US7062219B2
(en)
*
|
1997-01-31 |
2006-06-13 |
Odyssey Thera Inc. |
Protein fragment complementation assays for high-throughput and high-content screening
|
US7306914B2
(en)
*
|
1997-01-31 |
2007-12-11 |
Odyssey Thera Inc. |
Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
|
US6342345B1
(en)
|
1997-04-02 |
2002-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by reporter subunit complementation
|
DK1801214T3
(da)
|
1997-07-07 |
2011-01-24 |
Medical Res Council |
In vitro sorteringsfremgangsmåde
|
US6333154B1
(en)
*
|
1997-12-04 |
2001-12-25 |
Institut Pasteur |
Bacterial multi-hybrid system and applications thereof
|
US20050221280A1
(en)
*
|
1998-02-02 |
2005-10-06 |
Odyssey Thera, Inc. |
Protein-protein interactions for pharmacological profiling
|
US6828099B2
(en)
*
|
1998-02-02 |
2004-12-07 |
Odyssey Thera Inc. |
Protein fragment complementation assay (PCA) for the detection of protein-protein, protein-small molecule and protein nucleic acid interactions based on the E. coli TEM-1 β-Lactamase
|
US7855167B2
(en)
*
|
1998-02-02 |
2010-12-21 |
Odyssey Thera, Inc. |
In vivo screening of protein-protein interactions with protein-fragment complementation assays
|
US7166424B2
(en)
*
|
1998-02-02 |
2007-01-23 |
Odyssey Thera Inc. |
Fragments of fluorescent proteins for protein fragment complementation assays
|
AU756617B2
(en)
|
1998-07-28 |
2003-01-16 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Leptin-mediated gene-induction
|
AU5143099A
(en)
*
|
1998-07-30 |
2000-02-21 |
Universite De Montreal |
Protein fragment complementation assays for the detection of biological or drug interactions
|
JP2002526756A
(ja)
*
|
1998-09-24 |
2002-08-20 |
デューク ユニバーシティ |
生細胞におけるタンパク質−タンパク質相互作用の測定方法
|
EP1117762A4
(de)
|
1998-09-29 |
2004-02-25 |
Gamida Cell Ltd |
Verfahren zur kontrolle der proliferation und differenzierung von stammzellen und vorläuferzellen
|
US20040038317A1
(en)
*
|
1999-03-15 |
2004-02-26 |
Kalobios, Inc. |
Breakpoint fusion fragment complementation system
|
US8148110B2
(en)
|
1999-03-15 |
2012-04-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by β-lactamase reporter fragment complementation
|
DE60036942T2
(de)
*
|
1999-05-24 |
2008-08-07 |
New England Biolabs, Inc., Beverly |
Verfahren zur herstellung von getrennten, nicht-übertragbaren genen, welche befähigt sind ein aktives proteinprodukt zu exprimieren
|
US20040096938A1
(en)
*
|
1999-05-24 |
2004-05-20 |
Ming-Qun Xu |
Method for generating split, non-transferable genes that are able to express an active protein product
|
AU6045900A
(en)
*
|
1999-05-25 |
2000-12-12 |
Panorama Research, Inc. |
Interaction-activated proteins
|
US6673554B1
(en)
*
|
1999-06-14 |
2004-01-06 |
Trellie Bioinformatics, Inc. |
Protein localization assays for toxicity and antidotes thereto
|
EP1194539A2
(de)
*
|
1999-06-25 |
2002-04-10 |
Universität Zürich |
Hetero-assoziierende coiled-coil peptide und screenings-verfahren dafür
|
WO2001000866A1
(en)
|
1999-06-26 |
2001-01-04 |
Odyssey Pharmaceuticals, Inc. |
An in vivo library-versus-library selection of optimized protein-protein interactions
|
WO2001001137A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Children's Medical Center Corporation |
Fusion protein and uses thereof
|
AU6363900A
(en)
*
|
1999-07-22 |
2001-02-13 |
Children's Medical Center Corporation |
Expression cloning using a tagged cdna library
|
WO2001051629A2
(en)
*
|
2000-01-13 |
2001-07-19 |
Panorama Research, Inc. |
Circularly permutated, interaction-activated proteins
|
WO2001053479A2
(en)
*
|
2000-01-24 |
2001-07-26 |
Sangamo Biosciences, Inc. |
Molecular switches ii
|
WO2001060840A2
(en)
*
|
2000-02-14 |
2001-08-23 |
Board Of Regents, The University Of Texas System |
Complementation assay assessing protein solubility and folding
|
US6727070B2
(en)
|
2000-02-14 |
2004-04-27 |
The Board Of Regents, The University Of Texas System |
Protein/solubility folding assessed by structural complementation
|
US6780599B2
(en)
|
2000-05-12 |
2004-08-24 |
Yale University |
Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins
|
WO2001088168A2
(en)
*
|
2000-05-12 |
2001-11-22 |
Odyssey Pharmaceuticals, Inc. |
Mapping molecular interactions in plants with protein fragments complementation assays
|
DE60112282T2
(de)
*
|
2000-05-22 |
2006-04-20 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Auf rezeptorgrundlage arbeitende screening-verfahren für protein wechselwirkungen
|
WO2002020565A2
(en)
|
2000-09-08 |
2002-03-14 |
Universität Zürich |
Collections of repeat proteins comprising repeat modules
|
GB0022458D0
(en)
*
|
2000-09-13 |
2000-11-01 |
Medical Res Council |
Directed evolution method
|
DE60239097D1
(de)
*
|
2001-03-02 |
2011-03-17 |
Gpc Biotech Ag |
Drei-hybrid-assaysystem
|
DE10110449A1
(de)
*
|
2001-03-05 |
2002-09-19 |
Lisa Wiesmueller |
Testsystem zur Bestimmung von Genotoxizitäten
|
US20020177217A1
(en)
*
|
2001-03-26 |
2002-11-28 |
Massachusetts Institute Of Technology |
Method for studying protein-protein interactions
|
EP1392870B1
(de)
*
|
2001-05-09 |
2008-02-27 |
Discoverx, Inc. |
Screening auf enzyminhibitoren
|
DE60234131D1
(de)
*
|
2001-08-01 |
2009-12-03 |
Cellomics Inc |
Neue fusionsproteine und molekulare bindungsassays
|
GB0118995D0
(en)
*
|
2001-08-03 |
2001-09-26 |
Univ Wales Medicine |
Detection of mutations in nucleic acids
|
AU2007200686B2
(en)
*
|
2001-09-20 |
2011-07-14 |
Immunex Corporation |
Selection of cells expressing heteromeric polypeptides
|
WO2003035887A1
(en)
*
|
2001-09-20 |
2003-05-01 |
Immunex Corporation |
Selection of cells expressing heteromeric polypeptides
|
GB0127564D0
(en)
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
WO2003046176A2
(en)
|
2001-11-26 |
2003-06-05 |
Hybrigenics |
Protein-protein interactions in human immunodeficiency virus
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
EP1465982A4
(de)
*
|
2002-01-25 |
2006-06-07 |
Gamida Cell Ltd |
Verfahren zur expansion von stamm- und vorläuferzellen und damit erhaltene expandierte zellpopulationen
|
US6936427B2
(en)
*
|
2002-02-08 |
2005-08-30 |
Trellis Bioscience, Inc. |
Real time detection of intermolecular interaction
|
US7335478B2
(en)
*
|
2002-04-18 |
2008-02-26 |
Kalobios Pharmaceuticals, Inc. |
Reactivation-based molecular interaction sensors
|
US7432063B2
(en)
*
|
2002-02-14 |
2008-10-07 |
Kalobios Pharmaceuticals, Inc. |
Methods for affinity maturation
|
SE0200531D0
(sv)
*
|
2002-02-22 |
2002-02-22 |
Avaris Ab |
Novel biomolecular complexes, method for their production and use
|
ATE377644T1
(de)
*
|
2002-03-25 |
2007-11-15 |
Applera Corp |
Systeme und verfahren zum nachweis der funktion nukleärer rezeptoren unter verwendung von reporterenzymmutanten komplementierungen
|
WO2003093793A2
(en)
*
|
2002-05-01 |
2003-11-13 |
Trellis Bioscience, Inc. |
Binary or polynary targeting and uses thereof
|
GB0214553D0
(en)
*
|
2002-06-25 |
2002-08-07 |
Univ Leeds |
Reporter module molecules having active ion channel activity
|
US7662554B2
(en)
*
|
2002-10-09 |
2010-02-16 |
The Trustees Of Boston University |
Nucleic acid supported protein complementation
|
US9740817B1
(en)
|
2002-10-18 |
2017-08-22 |
Dennis Sunga Fernandez |
Apparatus for biological sensing and alerting of pharmaco-genomic mutation
|
EP1590477B1
(de)
|
2003-01-29 |
2009-07-29 |
454 Corporation |
Verfahren zur amplifikation und sequenzierung von nukleinsäuren
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
WO2005001115A2
(en)
*
|
2003-05-30 |
2005-01-06 |
Odyssey Thera, Inc. |
Monitoring gene silencing and annotating gene function in living cells
|
US8048627B2
(en)
|
2003-07-05 |
2011-11-01 |
The Johns Hopkins University |
Method and compositions for detection and enumeration of genetic variations
|
US8346482B2
(en)
|
2003-08-22 |
2013-01-01 |
Fernandez Dennis S |
Integrated biosensor and simulation system for diagnosis and therapy
|
CA2541765A1
(en)
|
2003-10-10 |
2004-10-01 |
Promega Corporation |
Luciferase biosensor
|
GB0329353D0
(en)
*
|
2003-12-19 |
2004-01-21 |
Amersham Biosciences Uk Ltd |
Cytochrome C protein and assay
|
WO2005077125A2
(en)
*
|
2004-02-11 |
2005-08-25 |
Applera Corporation |
Methods and compositions for detecting nucleic acids
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
AU2005250333A1
(en)
*
|
2004-04-16 |
2005-12-15 |
Genentech, Inc. |
Omi PDZ modulators
|
AU2005250369A1
(en)
*
|
2004-05-18 |
2005-12-15 |
Genentech, Inc. |
M13 virus major coat protein variants for C-terminal and BI-terminal display of a heterologous protein
|
US8586294B2
(en)
|
2004-05-18 |
2013-11-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of protein translocation by beta-galactosidase reporter fragment complementation
|
US20090221440A1
(en)
*
|
2004-07-12 |
2009-09-03 |
Board Of Regents, The University Of Texas System |
Methods and compositions related to identifying protein-protein interactions
|
EP2336177A1
(de)
|
2004-08-04 |
2011-06-22 |
Amgen, Inc |
DKK-1 Antikörper
|
US20060040338A1
(en)
|
2004-08-18 |
2006-02-23 |
Odyssey Thera, Inc. |
Pharmacological profiling of drugs with cell-based assays
|
WO2006030442A2
(en)
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
US20060094059A1
(en)
*
|
2004-09-22 |
2006-05-04 |
Odyssey Thera, Inc. |
Methods for identifying new drug leads and new therapeutic uses for known drugs
|
EP1797427A4
(de)
*
|
2004-09-22 |
2009-04-08 |
Odyssey Thera Inc |
Verfahren zur identifizierung neuer arzneimittel-leads und neuer therapeutischer verwendungen für bekannte arzneimittel
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
US20060094682A1
(en)
|
2004-10-29 |
2006-05-04 |
Odyssey Thera, Inc. |
Kinase inhibitors for the treatment of diabetes and obesity
|
CA2585549A1
(en)
|
2004-11-18 |
2006-05-26 |
Vib Vzw |
Novel type leptin receptor antagonist
|
US20060160109A1
(en)
*
|
2004-11-22 |
2006-07-20 |
Odyssey Thera, Inc. |
Harnessing network biology to improve drug discovery
|
US20070212677A1
(en)
*
|
2004-11-22 |
2007-09-13 |
Odyssey Thera, Inc. |
Identifying off-target effects and hidden phenotypes of drugs in human cells
|
EP1828408A4
(de)
*
|
2004-12-04 |
2008-08-27 |
Univ California Los Alamos Nat |
Nachweissystem für protein-protein-wechselwirkungen unter verwendung von fluoreszenzproteinmikrodomänen
|
US20060204999A1
(en)
*
|
2005-03-14 |
2006-09-14 |
Stephen Macevicz |
Detecting molecular complexes
|
US8227572B2
(en)
*
|
2005-08-19 |
2012-07-24 |
Commonwealth Scientific And Industrial Research Organisation |
Arachnocampa luciferases
|
JP2009513141A
(ja)
*
|
2005-10-27 |
2009-04-02 |
トラスティーズ オブ ボストン ユニバーシティ |
タンパク質相補によるリアルタイムインビボ核酸検出
|
US20090220942A1
(en)
*
|
2005-10-27 |
2009-09-03 |
Natalia Broude |
Activated split-polypeptides and methods for their production and use
|
GB0523954D0
(en)
*
|
2005-11-24 |
2006-01-04 |
Ucb Celltech |
Bioassays
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
US7601517B2
(en)
|
2006-01-10 |
2009-10-13 |
Stanford University |
Split protein self complementing fragments, systems, and methods of use thereof
|
CA2636855C
(en)
|
2006-01-11 |
2016-09-27 |
Raindance Technologies, Inc. |
Microfluidic devices and methods of use in the formation and control of nanoreactors
|
WO2008018905A2
(en)
*
|
2006-01-17 |
2008-02-14 |
Cellumen, Inc. |
Method for predicting biological systems responses
|
US9359635B2
(en)
|
2006-04-03 |
2016-06-07 |
Promega Corporation |
Permuted and nonpermuted luciferase biosensors
|
US7695928B2
(en)
|
2006-04-10 |
2010-04-13 |
Genentech, Inc. |
Disheveled PDZ modulators
|
US20070254338A1
(en)
*
|
2006-04-24 |
2007-11-01 |
Amgen Inc. |
Method for making recombinant protein using complementation dependent DHFR mutants
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
EP3031918B1
(de)
|
2006-05-11 |
2018-03-14 |
Raindance Technologies Inc. |
Mikrofluidische vorrichtungen
|
JP5406019B2
(ja)
|
2006-05-17 |
2014-02-05 |
セルーメン、インコーポレイテッド |
自動化組織分析のための方法
|
US8178654B2
(en)
|
2006-05-23 |
2012-05-15 |
Stanford University |
Estrogen receptor intramolecular folding systems, estrogen receptor intramolecular folding sensors, methods of use thereof, methods of detecting ER ligands, and methods of detecting ER agonists and antagonists
|
WO2008021123A1
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
MX2009004464A
(es)
*
|
2006-10-27 |
2009-11-02 |
Univ Boston |
Conjugados biomoleculares divididos, dirigidos para el tratamiento de enfermedades, malignidades y desordenes, y metodos para su produccion.
|
EP2095119A2
(de)
*
|
2006-11-10 |
2009-09-02 |
Cellumen, Inc. |
Biosensoren für protein-protein-interaktion und verfahren zu ihrer verwendung
|
EP2118304A4
(de)
*
|
2007-02-05 |
2010-04-28 |
Panbio Ltd |
Homogene in-vitro-fec-testverfahren und komponenten
|
WO2008097559A2
(en)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
WO2008130623A1
(en)
|
2007-04-19 |
2008-10-30 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
US20090075313A1
(en)
*
|
2007-05-04 |
2009-03-19 |
Stanford University |
Split protein fragments, split protein systems, methods of making split protein systems, and methods of using split protein systems
|
EP2177611B1
(de)
|
2007-08-01 |
2013-11-20 |
Japan Science and Technology Agency |
Verfahren zur messung der antigenkonzentration
|
WO2009026303A1
(en)
|
2007-08-21 |
2009-02-26 |
Amgen Inc. |
Human c-fms antigen binding proteins
|
US8986997B2
(en)
*
|
2007-08-31 |
2015-03-24 |
The Regents Of The University Of Michigan |
Methods and compositions for increasing biological molecule stability
|
TW200918553A
(en)
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
EP2210104A4
(de)
*
|
2007-11-01 |
2011-02-23 |
Univ Arizona State |
Zellfreie verfahren zum nachweis von protein-ligand-wechselwirkungen
|
EP2220247A4
(de)
|
2007-11-16 |
2011-10-26 |
Nuvelo Inc |
Antikörper gegen lrp6
|
WO2009111073A2
(en)
*
|
2008-03-06 |
2009-09-11 |
Odyssey Thera, Inc. |
High-content and high throughput assays for identification of lipid-regulating pathways, and novel therapeutic agents for lipid disorders
|
WO2009142735A2
(en)
|
2008-05-19 |
2009-11-26 |
Promega Corporation |
LUCIFERASE BIOSENSORS FOR cAMP
|
EP2315629B1
(de)
|
2008-07-18 |
2021-12-15 |
Bio-Rad Laboratories, Inc. |
Tröpfchenbibliotheken
|
JP5739807B2
(ja)
*
|
2008-08-18 |
2015-06-24 |
ディスカヴァーエックス コーポレイション |
受容体チロシンキナーゼアッセイ
|
JP5954990B2
(ja)
|
2008-11-03 |
2016-07-20 |
モレキュラー・パートナーズ・アーゲーMolecular Partners Ag |
Vegf−aレセプター相互作用を阻害する結合タンパク質
|
US9388406B2
(en)
|
2008-11-17 |
2016-07-12 |
Cornell University |
System useful for reporting protein-protein interactions in the bacterial periplasm
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
WO2010111231A1
(en)
|
2009-03-23 |
2010-09-30 |
Raindance Technologies, Inc. |
Manipulation of microfluidic droplets
|
US8871686B2
(en)
|
2009-07-07 |
2014-10-28 |
Agency For Science, Technology And Research |
Methods of identifying a pair of binding partners
|
US8524457B2
(en)
|
2009-09-22 |
2013-09-03 |
William Patterson |
Method for the selection of specific affinity binders by homogeneous noncompetitive assay
|
US10520500B2
(en)
|
2009-10-09 |
2019-12-31 |
Abdeslam El Harrak |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
JO3244B1
(ar)
|
2009-10-26 |
2018-03-08 |
Amgen Inc |
بروتينات ربط مستضادات il – 23 البشرية
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
EP2517025B1
(de)
|
2009-12-23 |
2019-11-27 |
Bio-Rad Laboratories, Inc. |
Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
CA2789425C
(en)
|
2010-02-12 |
2020-04-28 |
Raindance Technologies, Inc. |
Digital analyte analysis with polymerase error correction
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
MX2012011986A
(es)
|
2010-04-15 |
2013-03-05 |
Amgen Inc |
RECEPTOR FGF HUMANO Y PROTEINAS ENLAZADAS A ß-KLOTHO.
|
AR081361A1
(es)
|
2010-04-30 |
2012-08-29 |
Molecular Partners Ag |
Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a
|
WO2011143339A1
(en)
|
2010-05-11 |
2011-11-17 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
US9290794B2
(en)
|
2010-05-11 |
2016-03-22 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
US9562897B2
(en)
|
2010-09-30 |
2017-02-07 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
AR083740A1
(es)
|
2010-10-27 |
2013-03-20 |
Amgen Inc |
Anticuerpos dkk1 (dickkopf-1) y metodos de uso
|
CA2818990C
(en)
|
2010-11-26 |
2021-06-15 |
Molecular Partners Ag |
Designed repeat proteins binding to serum albumin
|
EP2673614B1
(de)
|
2011-02-11 |
2018-08-01 |
Raindance Technologies, Inc. |
Verfahren zur bildung gemischter tröpfchen
|
US9150852B2
(en)
|
2011-02-18 |
2015-10-06 |
Raindance Technologies, Inc. |
Compositions and methods for molecular labeling
|
WO2012118903A2
(en)
|
2011-03-01 |
2012-09-07 |
Amgen Inc. |
Bispecific binding agents
|
EP2686688B1
(de)
|
2011-03-17 |
2019-05-08 |
Cernostics, Inc. |
Systeme und zusammensetzungen zur diagnose von barrett-ösophagen und verwendungsverfahren dafür
|
EP2702069A4
(de)
|
2011-04-29 |
2015-04-29 |
Janssen Biotech Inc |
Il4/il13-bindende repeat-proteine und verwendungen davon
|
EP2714970B1
(de)
|
2011-06-02 |
2017-04-19 |
Raindance Technologies, Inc. |
Enzymquantifizierung
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
US9574002B2
(en)
|
2011-06-06 |
2017-02-21 |
Amgen Inc. |
Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
WO2013033080A1
(en)
*
|
2011-08-29 |
2013-03-07 |
Wayne State University |
Device and method for optimizing photobiological processes
|
MX2014004027A
(es)
|
2011-10-14 |
2014-04-30 |
Genentech Inc |
Activadores de zimogeno.
|
CA2858572C
(en)
|
2011-12-08 |
2023-01-17 |
Amgen Inc. |
Human lcat antigen binding proteins and their use in therapy
|
CN104204192A
(zh)
|
2012-02-13 |
2014-12-10 |
加米达细胞有限公司 |
间充质干细胞调理的基质及其产生和使用方法
|
EP2825549B1
(de)
|
2012-03-16 |
2018-10-10 |
F. Hoffmann-La Roche SA |
Gleichmässig stabilisierte manipulierte proteine
|
US9139863B2
(en)
|
2012-03-16 |
2015-09-22 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
IL307989A
(en)
|
2012-04-27 |
2023-12-01 |
Novo Nordisk As |
Human CD30 ligand antigen-binding proteins
|
BR112014032316A2
(pt)
|
2012-06-28 |
2017-06-27 |
Molecular Partners Ag |
proteínas de repetição de anquirina projetadas que se ligam ao fator de crescimento derivado de plaqueta
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
EP2738180A1
(de)
|
2012-11-30 |
2014-06-04 |
Molecular Partners AG |
Bindeproteine mit mindestens zwei Bindedomänen gegen HER2
|
US20140271629A1
(en)
|
2013-03-14 |
2014-09-18 |
Amgen Inc. |
Chrdl-1 antigen binding proteins and methods of treatment
|
SG11201507306VA
(en)
|
2013-03-15 |
2015-10-29 |
Promega Corp |
Activation of bioluminescence by structural complementation
|
EP3683237A1
(de)
|
2013-03-15 |
2020-07-22 |
Amgen Inc. |
Humane pac1-antikörper
|
WO2014144553A1
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Secreted frizzle-related protein 5 (sfrp5) binding proteins and methods of treatment
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
US11193176B2
(en)
|
2013-12-31 |
2021-12-07 |
Bio-Rad Laboratories, Inc. |
Method for detecting and quantifying latent retroviral RNA species
|
EP3094974B1
(de)
|
2014-01-14 |
2019-02-27 |
Asedasciences AG |
Identifizierung von funktionszellzuständen
|
AU2015224552A1
(en)
*
|
2014-03-03 |
2016-09-15 |
Novogy, Inc. |
Reducing horizontal gene transfer of functional proteins
|
WO2015192089A1
(en)
|
2014-06-12 |
2015-12-17 |
Axion Biosystems, Inc. |
Multiwell microelectrode array with optical stimulation
|
CN106605382B
(zh)
*
|
2014-08-27 |
2020-11-06 |
Lg 电子株式会社 |
在无线通信系统中的发送数据的方法及用于其装置
|
CN105406948B
(zh)
*
|
2014-09-12 |
2020-03-06 |
中兴通讯股份有限公司 |
一种实现并行多用户数据传输的方法及主节点
|
WO2016040767A2
(en)
|
2014-09-12 |
2016-03-17 |
Amgen Inc. |
Chrdl-1 epitopes and antibodies
|
CA2963228C
(en)
*
|
2014-10-01 |
2021-05-04 |
Lg Electronics Inc. |
Data transmission method in wireless communication system and device therefor
|
US9942055B2
(en)
*
|
2015-02-12 |
2018-04-10 |
Intel IP Corporation |
Apparatus, system and method of multicast communication
|
JOP20200116A1
(ar)
|
2015-04-24 |
2017-06-16 |
Amgen Inc |
طرق لعلاج أو الوقاية من الصداع النصفي
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
MX2018007859A
(es)
|
2015-12-23 |
2018-11-09 |
Amgen Inc |
Metodo para tratar o mejorar trastornos metabolicos con proteinas de union para el receptor peptidico inhibidor gastrico (gipr) en combinacion con agonistas de glp-1.
|
WO2017182437A1
(en)
|
2016-04-18 |
2017-10-26 |
Universität Innsbruck |
Quantification of an interaction between a ras protein and a raf protein
|
US10239891B2
(en)
*
|
2017-05-15 |
2019-03-26 |
Indicator Systems International, Inc. |
Compositions to detect remnant cancer cells
|
WO2018026965A1
(en)
|
2016-08-02 |
2018-02-08 |
Isi Life Sciences, Inc. |
Compositions and methods for detecting cancer cells in a tissue sample
|
EP3497231B1
(de)
*
|
2016-08-08 |
2023-10-04 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bakterielle systeme zur analyse von ubiquitinierten polypeptiden
|
WO2018060415A1
(en)
|
2016-09-29 |
2018-04-05 |
Universität Innsbruck |
Full length kinase activity-conformation reporter
|
AU2018206279B2
(en)
|
2017-01-06 |
2020-09-03 |
Abl Bio Inc. |
Anti-alpha-syn antibody and use thereof
|
JOP20190177A1
(ar)
|
2017-01-17 |
2019-07-16 |
Amgen Inc |
طريقة لعلاج أو تحسين اضطرابات أيضية باستخدام مساعدات مستقبل glp-1 مقترنة بمناهضات لمستقبل ببتيد مثبط معوي (gipr)
|
US10753942B2
(en)
|
2017-05-15 |
2020-08-25 |
Indicator Systems International, Inc. |
Methods to detect remnant cancer cells
|
JOP20190259A1
(ar)
|
2017-05-31 |
2019-10-31 |
Amgen Inc |
بروتينات ربط مولد ضد مضادة لـ jagged1
|
WO2018237097A1
(en)
|
2017-06-20 |
2018-12-27 |
Amgen Inc. |
METHOD OF TREATING OR REDUCING METABOLIC DISORDERS USING GASTRIC INHIBITING PEPTIDE RECEPTOR BINDING PROTEINS (GIPR) IN ASSOCIATION WITH GLP-1 AGONISTS
|
CA3071852A1
(en)
|
2017-08-04 |
2019-02-07 |
Amgen Inc. |
Method of conjugation of cys-mabs
|
US11932846B2
(en)
|
2017-08-08 |
2024-03-19 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Chloramphenicol resistant split protein and uses thereof
|
WO2019225787A1
(ko)
|
2018-05-24 |
2019-11-28 |
에이비엘바이오 주식회사 |
항-b7-h3 항체 및 그 용도
|
EP4266058A3
(de)
|
2018-07-06 |
2024-02-21 |
The Regents of the University of Colorado, a body corporate |
Genetisch codiertes system zur konstruktion und zum nachweis biologischer wirkstoffe
|
CN111198272B
(zh)
*
|
2018-11-20 |
2023-09-08 |
香港理工大学深圳研究院 |
体外检测蛋白间相互作用的方法和检测试剂盒及其应用
|
MX2021006783A
(es)
|
2018-12-10 |
2021-07-15 |
Amgen Inc |
Transposasa de piggybac mutada.
|
CA3153963A1
(en)
*
|
2019-09-09 |
2021-03-18 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods of restoring lysosomal function of retinal pigment epithelial cells by activation of tfeb
|
EP4054590A1
(de)
|
2019-11-04 |
2022-09-14 |
Amgen Inc. |
Verfahren zur behandlung von leukämie
|
CA3165802A1
(en)
*
|
2020-01-25 |
2021-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions for small molecule control of precise base editing of target nucleic acids and methods of use thereof
|
US20230184765A1
(en)
|
2020-04-17 |
2023-06-15 |
Vyriad, Inc. |
Detection assays for coronavirus neutralizing antibodies
|
AU2021345124A1
(en)
|
2020-09-16 |
2023-03-30 |
Amgen Inc. |
Methods for administering therapeutic doses of bispecific T-cell engaging molecules for the treatment of cancer
|
WO2022060878A1
(en)
|
2020-09-16 |
2022-03-24 |
Amgen Inc. |
Methods for treating prostate cancer
|
TW202233660A
(zh)
|
2020-10-30 |
2022-09-01 |
美商安進公司 |
過表現胰島素樣生長因子受體突變體以調節igf補充
|
CN112375775A
(zh)
*
|
2020-11-16 |
2021-02-19 |
中南民族大学 |
一种基于片段化萤光素酶-dna嵌合体互补的发光体系、构建方法及其应用
|
IL302739A
(en)
*
|
2020-11-17 |
2023-07-01 |
Nerd Bio Llc |
High-throughput drug screening methods
|
WO2022232376A1
(en)
|
2021-04-29 |
2022-11-03 |
Amgen Inc. |
Methods for reducing low molecular weight species of recombinantly-produced proteins
|
CA3222782A1
(en)
|
2021-06-10 |
2022-12-15 |
Amgen Inc. |
Engineered nrg-1 variants with improved selectivity toward erbb4 but not against erbb3
|
TW202328442A
(zh)
|
2021-09-10 |
2023-07-16 |
美商安進公司 |
平臺宿主對igf—培養基之適應
|
WO2023183231A1
(en)
|
2022-03-21 |
2023-09-28 |
Amgen Inc. |
Combination therapy methods with t-cell engaging molecules for treatment of prostate cancer
|
WO2024064744A2
(en)
*
|
2022-09-20 |
2024-03-28 |
Dna Twopointo, Inc. |
Engineered split dhfr-based methods and systems for selecting cells that have stably acquired a heterologous polynucleotide
|
WO2024077044A1
(en)
|
2022-10-05 |
2024-04-11 |
Amgen Inc. |
Combination therapies comprising t-cell redirecting therapies and agonistic anti-il-2r antibodies or fragments thereof
|
WO2024089297A1
(en)
|
2022-10-28 |
2024-05-02 |
Urban Joerg |
Novel fluorescent and bioluminescent proteins and reporter systems for ratiometric measurement of luminescence
|